Zydus Heptiza

This category of Zydus Heptiza includes certain chemotherapy agents that are prescribed for treating lung, breast, & ovarian cancers, Kaposi’s sarcoma, and cervical cancer. They have paclitaxel and gemcitabine as active compounds that bind to beta-tubulin subunits of microtubules for exerting therapeutic effects. These medicines can also prevent the formation of new DNA strand in tumor cells which causes their death. They show good protein binding ability of 89 to 98% with hepatic metabolism which is assisted by CYP2C8 & CYP3A4. These drugs show no serious health effects if consumed under prescription.